Animation - Understanding NSCLC Treatment Options When You Have an EGFR Mutation

This animation provides an overview of EGFR mutations in non-small cell lung cancer (NSCLC) and different treatment options. The good news is that specific treatments can target EGFR mutations. If you have an EGFR mutation, you may be a candidate for targeted therapy, and there are many treatments that target EGFR. Watch to learn about tyrosine kinase inhibitors (TKIs), monoclonal antibody drugs, managing side effects, the importance of repeat biomarker testing, clinical trials, and more.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.

Other Modules:

Patient Stories: